Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Clinical trial NCT05187338 · RECRUITING
Trial details
- NCT number
- NCT05187338
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2029-10-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.